Trending

Antibody Engineering

Otsuka has high hopes for its ‘drug creation engine’ acquisition

Otsuka is paying $430 million for a US clinical-stage biotech company it hopes will act as a ‘drug

X

Otsuka has high hopes for its ‘drug creation engine’ acquisition

https://pharmaphorum.com/news/otsuka-biotech-visterra-hierotope/

Immuno-Oncology Summit

02-03 October 2018 Austria Vienna Hilton Garden Inn Vie

X

Immuno-Oncology Summit

https://pharmaphorum.com/events/immuno-oncology-summit/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com